Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cannasouth shares (CBD)

Your step-by-step guide to buying CBD shares on the New Zealand Exchange.

Cannasouth logo

Cannasouth is a New Zealand pharmaceutical company that specialises in the development of medicinal cannabis products. Cannasouth shares (CBD) can be bought and sold on the New Zealand Stock Exchange (NZX). Keep reading to find out how.

About our promoted products: Our ‘promoted’ products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you.
Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high risk of losing all of or more than their initial investment

How to buy shares in Cannasouth on the New Zealand Exchange

  1. Compare share trading platforms. If you’re a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table. Most importantly, you need to find a share trading platform that allows you to trade on the NZX.
  2. Open and fund your share trading account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cannasouth. Find the stock by name or ticker symbol: CBD. Research its history to confirm it’s a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cannasouth reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market’s ups and downs. You may be able to buy a fractional share of Cannasouth, depending on your share trading account.
  6. Check in on your investment. Congratulations, you own a part of Cannasouth. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare NZX share trading platforms

Name Product Available Investment Types Min. Monthly Fee Available Markets
Shares, ETFs, Managed Funds, Index Funds
US, NZ, AU, Funds with exposure to multiple markets
Trade and invest in more than 3,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
ASB Securities
Shares, ETFs, Bonds
NZ, AU, Funds with exposure to multiple markets
Direct Broking
Shares, ETFs, Bonds
$5 per month
NZ, AU, Funds with exposure to multiple markets

Compare up to 4 providers

Cannasouth overview and background

Founded in 2018, Cannasouth is a Waikato-based pharmaceutical company. Following the completion of an IPO that raised $10 million, Cannasouth Limited was listed on the NZX in June 2019.

Cannasouth Limited is also the parent company of Cannasouth Bioscience Limited, a subsidiary focused on researching and developing medicinal cannabis products.

The company’s aim is to develop cannabinoid therapeutics to help improve outcomes and quality of life for patients with a wide range of health issues. Its products will be manufactured in the manufacturing and packing facility of Midwest Pharmaceutics, a company in which Cannasouth acquired a 60% share in October 2019.

Performance and company results

In its 2020 half-year report, released in August 2020, Cannasouth Limited reported an operating loss for the six months to 30 June 2020 of $1,451,650. Cash on hand at this date was $10.18 million.

The company also completed a share purchase plan in May 2020 that raised over $6 million.

Key details

NameCannasouth LimitedIndustryBiopharmaceutical & Research
Ticker symbolCBDISINNZCBDE0009S6
TypeOrdinary sharesDate listed on NZX19 Jun 2019
End of financial yearDecemberChief executive officerMark Lucas
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site